"The voice of oncology in Massachusetts."

KEYTRUDA(R) (pembrolizumab): Learn About an Additional Indication

March 28, 2023 9:59 AM | Katy Monaco (Administrator)
Information from Merck announcing a new indication linked below.

Click to Download.

For prescribers: please click here for state-required price disclosures.

Massachusetts Society of Clinical Oncologists ©2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software